Pantoprazol Kalceks (Pantoprazole)

Pantoprazol Kalceks is a proton pump inhibitor used in the management of acid‑related disorders of the gastrointestinal tract.

• Gastro‑oesophageal reflux disease (GERD): reduces stomach acid production to relieve heartburn and esophageal irritation.
• Erosive oesophagitis: promotes healing of acid‑induced esophageal lesions.
• Zollinger‑Ellison syndrome: controls excessive gastric acid secretion associated with gastrin‑producing tumors.
• Peptic ulcer disease: supports ulcer healing by maintaining a less acidic gastric environment.
• NSAID‑induced ulcer prophylaxis: lowers risk of ulcer formation in patients requiring long‑term non‑steroidal anti‑inflammatory drug therapy.

• Pantoprazole selectively and irreversibly inhibits the H+/K+‑ATPase enzyme (the gastric proton pump) located on the secretory surface of parietal cells. By blocking this final step of acid secretion, it markedly reduces gastric acidity, allowing mucosal healing and symptom relief in acid‑related gastrointestinal conditions.

Pantoprazol Kalceks may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects

• Headache: mild to moderate intensity.
• Diarrhoea: loose stools occurring intermittently.
• Nausea: feeling of queasiness without vomiting.
• Abdominal pain: mild cramping or discomfort.
• Flatulence: increased intestinal gas.
• Constipation: reduced bowel movements.

Serious or Rare Side Effects

• Severe allergic reaction: rash, itching, swelling, or difficulty breathing.
• Clostridioides difficile infection: persistent watery diarrhoea indicating possible colitis.
• Low magnesium levels: muscle cramps, irregular heartbeat, or seizures.
• Bone fractures: increased risk with long‑term use.
• Liver enzyme elevation: signs of hepatic stress detectable in blood tests.
• Acute interstitial nephritis: kidney inflammation presenting with fever and flank pain.

When prescribing Pantoprazol Kalceks, clinicians should consider several safety aspects.

• Assess renal function: dose adjustment may be required in severe impairment.
• Monitor magnesium: long‑term therapy can lead to hypomagnesemia.
• Evaluate bone health: prolonged use may increase fracture risk.
• Review concomitant medications: potential for reduced absorption of drugs requiring acidic pH.
• Pregnancy and lactation: use only if clearly needed after risk‑benefit assessment.
• Store at ambient temperature: keep in original packaging, protect from moisture and direct sunlight.

Pantoprazol Kalceks can affect the pharmacokinetics of several co‑administered medicines.

Major Interactions (Avoid)

• Ketoconazole: reduced absorption due to increased gastric pH.
• Atazanavir: markedly decreased plasma concentrations, compromising antiviral efficacy.
• Clopidogrel: diminished activation, potentially lowering antiplatelet effect.

Moderate Interactions (Monitor Closely)

• Warfarin: possible increase in INR, requiring more frequent monitoring.
• Digoxin: slight rise in serum levels, may need dose adjustment.
• Methotrexate: increased exposure, especially at high doses.
• Iron supplements: decreased absorption, consider separate dosing times.